The CXCL9 serum levels were found to be significantly different between patients with NPC and healthy individuals (516.8±617.6 pg/mL vs. 170.7±375.0 pg/mL, P<0.0001; Figure 3). The gene discussed is CXCL9; the disease is nasopharyngeal carcinoma.